Published on 01/12/2025

Traceability into WMS/TMS: Handshakes That Work

Introduction to Traceability in Serialization and Aggregation

In the current climate of stringent regulatory demands, ensuring proper traceability throughout the pharmaceutical supply chain is paramount. With initiatives such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medicines Directive (FMD) in Europe, pharmaceutical companies must adopt robust serialization and aggregation strategies. These initiatives mandate comprehensive master data governance and detailed validation of user requirements specifications (URS), ensuring compliance with applicable regulations.

This article serves as a step-by-step tutorial on how to effectively implement traceability mechanisms into Warehouse Management Systems (WMS) and Track and Trace Management Systems (TMS). We will cover critical components, including master data flows, interface validation, reconciliation rules, exception handling, and audit trail reviews.

Step 1: Establishing User Requirements Specifications (URS)

The first step in implementing an effective traceability solution is to generate and finalize comprehensive User Requirements Specifications (URS). The URS document outlines functional and non-functional requirements that must be met by the WMS/TMS.

Key Elements to Include in URS:

• System Overview: A brief description of the system’s intended function within the larger supply chain.
• Data Requirements: Define what master data must be captured, such as products, batches, and serialization details.
• Process Flow: A detailed depiction of the aggregation hierarchy and how products are handled at each step.
• Compliance Needs: Reference to relevant regulatory guidelines such as DSCSA compliance and EU FMD requirements.

By documenting comprehensive URS, stakeholders can maintain alignment on the project’s scope and should ensure all requirements meet regulatory expectations, thus setting a solid foundation for later phases of validation.

Step 2: Design and Configuration of the WMS/TMS

Once the URS is completed, the next step is to design the WMS/TMS in accordance with these specifications. This involves collaboration between the validation, IT, and operational teams.

Considerations During Design:

• Data Integrity: Ensure that the system adheres to the principles of ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, and a data integrity framework) to prevent data manipulation.
• Aggregation Scenarios: Implement the aggregation hierarchy which can include the relationship paths from individual units to cases to pallets, facilitating accurate tracking throughout the supply chain.
• User Interfaces: Ensure user interfaces are intuitive and promote ease of data entry to reduce errors.

Consequently, the design phase directly influences validation outcomes and should focus on creating a user-friendly and compliant system while remaining adaptable for future enhancements.

Step 3: Interface Validation between Systems

With systems designed and configured, validation of interfaces becomes critical. Interface validation verifies that data flows correctly between disparate systems, such as between manufacturing systems and the WMS/TMS.

Actions to Validate Interfaces:

• Mapping Requirements: Identify required mappings for data fields between the systems, ensuring no information is lost in transition.
• Testing Techniques: Use methods such as Integration Testing and End-to-End Testing to verify data accuracy and completeness during handoffs.
• Error Handling Mechanisms: Document exception handling protocols to manage discrepancies in data transmission, which aids in robust auditing.

Step 4: Implementing Reconciliation Rules

Following successful interface validation, the next consideration is the establishment of reconciliation rules. This process ensures that data throughout the WMS/TMS aligns with the records in other systems, maintaining integrity.

Considerations for Reconciliation:

• Frequency: Define how often reconciliation should occur — whether in real-time, daily, or weekly, depending on operational requirements.
• Data Points: Identify critical data points required for reconciliation, such as serialized numbers and batch details.
• Reporting Mechanisms: Provide documentation of reconciled data discrepancies for an audit trail review, facilitating transparent and regulatory-compliant operations.

By implementing effective reconciliation rules, organizations can significantly minimize errors and maintain operational efficiency, meeting both internal policies and regulatory compliance requirements.

Step 5: Handling Exceptions and Rework Procedures

Despite best efforts, irregularities will arise in the serialization and aggregation processes. It is crucial to implement a robust exception handling and rework procedure.

Elements of Effective Exception Handling:

• Immediate Notifications: Automatically flag and notify stakeholders of any discrepancies, facilitating prompt attention and resolution.
• Documented Workflows: Develop clear procedures for how to address exceptions, ensuring all actions taken are in compliance with regulatory requirements.
• Audit Trail: Maintain comprehensive records of all exceptions and how they were handled, supporting future audits and inspections.

Writing down clear procedures and ensuring they are easily accessible will help staff navigate exceptions without confusion, maintaining compliance while enabling swift resolution.

Step 6: Conducting Audit Trail Reviews

Establishing robust audit trails is essential for compliance with regulatory requirements. An audit trail provides a detailed record of all transactions, user actions, and system changes. Regular reviews ensure that the audit trail remains intact and reliable.

Best Practices for Audit Trail Reviews:

• Regular Frequency: Schedule regular audits of the system and data entries to ensure adherence to established processes.
• Incident Logs: Maintain logs of incidents related to data integrity, reconciliation, and exceptions to identify patterns and prevent future issues.
• Regulatory Alignment: Ensure that audit trails align with both EMA and FDA regulations regarding data integrity and system documentation.

Incorporating audit trail reviews as a routine activity will not only meet compliance standards but also build a culture of accountability within the organization.

Step 7: Serialization Change Control

As the landscape of pharmaceutical manufacturing evolves, organizations must be proactive in managing changes to serialization processes. Establishing a clear serialization change control strategy is paramount in maintaining compliance and operational efficiency.

Key Aspects of Serialization Change Control:

• Documentation: All changes to the serialization processes must be thoroughly documented, including the rationale for the change, planned implementation timelines, and risk assessments.
• Stakeholder Involvement: Engage relevant stakeholders during the change control process to mitigate disruptions and promote informed decision-making.
• Training Requirements: Provide relevant training to affected personnel to ensure smooth transitions during serialization changes. This contributes to a culture of compliance and enhances data integrity.

A well-structured change control process for serialization helps mitigate risks associated with compliance and ensures that organizations can adapt to evolving legal and operational landscapes.

Conclusion: Achieving Robust Traceability in WMS/TMS

Traceability is not just an operational necessity but a regulatory requirement in the pharmaceutical supply chain. Implementing robust serialization and aggregation strategies through diligent attention to URS, interface validation, and ongoing data governance can significantly enhance compliance and operational efficiency.

By following the steps outlined in this tutorial, pharmaceutical professionals can ensure proper implementation of traceability systems in WMS/TMS, fostering a commitment to quality, safety, and compliance across the supply chain. As the industry continues to adapt to new challenges and regulations, embracing these best practices will support the integrity of pharmaceutical manufacturing and distribution processes globally.